Medical oncologists attitudes and practice in cancer pain management: A national survey

Journal of Clinical Oncology | November 28, 2011

Breuer B et al. – These data suggest that, for more than 20 years, a focus on cancer pain has not adequately addressed the perception of treatment barriers or limitations in pain–related knowledge and practice within the oncology community. Additional efforts are needed to achieve meaningful progress.

Methods

  • Anonymous survey was mailed to geographically representative sample of medical oncologists randomly selected from the American Medical Association's Physician Master File

Results

  • From total of 2,000 oncologists, 354 responded to the original questionnaire and 256 responded to one of 2 subsequent shortened versions (ORR, 32%)
  • Responders were demographically similar to all US medical oncologists
  • Using numeric rating scales of 0 to 10, oncologists rated their specialty highly for the ability to manage cancer pain (median, 7; interquartile range [IQR], 6 to 8) but rated their peers as more conservative prescribers than themselves (median, 3; IQR, 2 to 5)
  • Quality of pain management training during medical school and residency was rated as 3 (IQR, 1 to 5) and 5 (IQR, 3 to 7)
  • Most important barriers to pain management were poor assessment (median, 6; IQR, 4 to 7) and patient reluctance to take opioids (median, 6; IQR, 5 to 7) or report pain (median, 6; IQR, 4 to 7). Other barriers included physician reluctance to prescribe opioids (median, 5; IQR, 3 to 7) and perceived excessive regulation (median, 4; IQR, 2 to 7)
  • In response to 2 vignettes describing challenging clinical scenarios, 60% and 87% endorsed treatment decisions that would be considered unacceptable by pain specialists
  • Frequent referrals to pain or palliative care specialists were reported by only 14% and 16%

Read the full article on Journal of Clinical Oncology